HPV Diagnostic Testing Advances: Detecting Strains linked to Cervical Cancer

Life Science Webinars

Advances in HPV Diagnostic Testing: Technologies Enhancing Detection of High-Risk Strains Linked to Cervical Cancer

Topics:

With over 12 different types of human papilloma virus (HPV) that can cause cancer, it is the leading cause of cervical cancer in women. The HPV/Pap smear co-test has improved the accuracy of cervical cancer screening; however the test has several limitations. Recent advancements in molecular diagnostics have led to the development of genotype-specific HPV tests that accurately detect and differentiate HPV strains, including high-risk oncogenic types such as HPV-16 and HPV-18.

In this webinar you will:

Learn about HPV type-specific testing
Explore the recent trends in HPV diagnostics
Discover urine-specific genotyping chemistry, which can provide a non-invasive, sensitive method for HPV detection

Date/Time: Thu, Sep 19, 2024 11:00 AM – 12:00 PM EDT

Speaker: Steve Hawkins, Ph.D., Meridian Life Science Molecular Product Manager

Meridian is the complete solution

Meridian offers diagnostic manufacturers the complete solution with over 3,000 antigens and antibodies covering more than 500 diseases and an extensive range of specialty qPCR/RT-qPCR master mixes and molecular enzymes all manufactured under ISO13485 regulations.

MeridianSmartSearch

Get In Touch With A Specialist

Have questions about a product? Want to learn more about Meridian’s molecular or immunoassay reagent portfolio? We want to hear from you!